Overview

A Clinical Study to Determine Whether an Investigational Medication (SEP-363856) Changes How Long it Takes for Food to Move Through the Stomach Into the Small Intestine in Patients With Schizophrenia. The Study Will Help to Understand Any Effect SEP

Status:
Not yet recruiting

Trial end date:
2023-07-13

Target enrollment:

Participant gender:

Summary

A clinical study to determine whether an investigational medication (SEP363856) changes how long it takes for food to move through the stomach into the small intestine in patients with schizophrenia. This study is accepting both male and female subjects. It will be conducted in approximately 6 study sites in the United States. The duration of participation will be approximtely 10 weeks.

Phase:

Phase 1

Details

Lead Sponsor:

Sunovion

Treatments:

Antipsychotic Agents
Aripiprazole
Olanzapine
Quetiapine Fumarate
Risperidone